Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.
Copyright 2020 – Finance News Network
Source: Finance News Network
16 Jun 2022 - Knosys Limited (ASX:KNO) Managing Director John Thompson provides an update on the company, discussing demand drivers, recurring revenue and growth strategy.
Read More03 Aug 2020 - Kingston Resources Limited (ASX:KSN) Managing Director Andrew Corbett provides an update on the company's Misima and Livingstone Gold Projects.
Read More19 Apr 2022 - Novatti Group Limited (ASX:NOV) CEO and Managing Director Peter Cook discusses innovations in the payment space, strategy and outlook.
Read More27 Jul 2023 - The European Bank for Reconstruction and Development has agreed to invest 6 million euros to support European Metals Holdings' (ASX:EMH) development of the Cinovec lithium project in the Czech Republic.
Read More31 May 2023 - Ron Mitchell, Managing Director of Global Lithium Resources Limited (ASX:GL1), which owns two of the 14 lithium resources in Australia, discusses the price of lithium and progress on the company's projects.
Read More21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More25 March 2024 - Altech Batteries Limited (ASX:ATC) Managing Director Iggy Tan provides an update on the company, discussing funding pathways and the results of the DFS.
Read More21 Jun 2023 - Sayona Mining Limited (ASX:SYA) Finance Manager Dougal Elder discusses key takeaways from the recent lithium carbonate study, improvement in operation total value, and steps to get to first production in 2026.
Read More18 Oct 2019 - Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, talks about the company's strategy, recent capital raising, and results from the drill program at its Montney project.
Read More31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More
